Krystal Biotech, Inc. KRYS Business Segments — Income Tax Expense (Benefit)

Similar metrics at other companies

BBIOReportable Segment — Income Tax Expense (Benefit)

-$1.55M—

SOReportable Segment — Income taxes (benefit)

$129M+16.2%

ROIVReportable Segment — Income tax expense (benefit)

$98.35M+99.4%

LOGIReportable Segment — Income Tax Expense (Benefit)

$6.39M—

AKAMReportable Segment — Benefit (provision) for income taxes

$15.68M-68.8%

RMBSReportable — Income Tax Expense Benefit

$8.77M+19.8%

Questions, answered.

What is Krystal Biotech, Inc.'s business segments — income tax expense (benefit)?

Krystal Biotech, Inc. (KRYS) reported business segments — income tax expense (benefit) of $5.51M in Q1 2026.

How has Krystal Biotech, Inc.'s business segments — income tax expense (benefit) changed year-over-year?

Krystal Biotech, Inc.'s business segments — income tax expense (benefit) decreased by 29.9% year-over-year, from $7.86M to $5.51M.

What does business segments — income tax expense (benefit) mean?

The net tax cost or benefit recognized by the company for the period.

How do you interpret business segments — income tax expense (benefit)?

A benefit can improve net income, while a high expense reduces it; significant changes often reflect tax planning or changes in profitability.

How does business segments — income tax expense (benefit) compare across companies?

Tax rates vary significantly based on the company's geographic footprint and the utilization of net operating loss carryforwards.